A MULTIDISCIPLINARY APPROACH TO THE MANAGEMENT AND OUTCOMES OF SEVERE CUTANEOUS ADVERSE REACTIONS (SCARS): A COLLABORATIVE STUDY ON SYSTEMIC STABILITY, TOPICAL RECOVERY, AND PAIN MODULATION
Main Article Content
Keywords
SCARs, Multidisciplinary Care, Stevens-Johnson Syndrome, Pain Management, Systemic Stability, Dermatology, Anesthesiology.
Abstract
Background Severe Cutaneous Adverse Reactions (SCARs), including Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), are life-threatening conditions that demand rapid, integrated intervention. Given their complex nature, survival and long-term recovery depend on more than just dermatological care; they require intensive systemic stabilization and sophisticated pain management. This study evaluates the efficacy of a multidisciplinary protocol involving General Medicine, Dermatology, and Anesthesiology in improving patient outcomes.
Methods A retrospective observational study was conducted on patients diagnosed with SCARs over a defined clinical period. The "Multidisciplinary Care Model" was assessed based on three primary pillars:
- Systemic Stability: Evaluated by the General Medicine team through fluid resuscitation, electrolyte balance, and prevention of secondary organ failure.
- Topical Recovery: Managed by Dermatology via specialized wound care and topical immunomodulators.
- Pain Modulation: Orchestrated by Anesthesiology using multimodal analgesia and, where necessary, sedative protocols to facilitate dressing changes and reduce physiological stress.
Results Preliminary findings indicate that early integration of Anesthesiology-led pain modulation significantly reduced the incidence of patient distress during wound debridement and lowered the overall metabolic stress response. The General Medicine-led stabilization phase saw a 15\% reduction in acute kidney injury (AKI) compared to traditional fragmented care models. Dermatological outcomes showed accelerated re-epithelialization and a lower rate of secondary cutaneous infections when systemic parameters were strictly optimized.
Conclusion A collaborative, multidisciplinary approach is essential for the management of SCARs. The synergy between systemic medical support, specialized skin care, and proactive pain modulation not only improves acute survival rates but also enhances the quality of life during the recovery phase. This study supports the standardization of cross-departmental protocols for complex dermatological emergencies.
References
2. Srinivasan, A., Ananthy, V., Jenisha, J. V., Kumarappan, M., Shanmugam, S., & Karthik, V. (2025). Severe Cutaneous Adverse Reactions in a tertiary care hospital with perspectives on pharmacogenomics and personalised medicine. Indian Journal of Physiology and Pharmacology, 69(1).
3. Hama, N., Abe, R., Gibson, A., & Phillips, E. J. (2022). Drug-induced hypersensitivity syndrome (DIHS)/Drug reaction with eosinophilia and systemic symptoms (DRESS): clinical features and pathogenesis. Journal of Allergy and Clinical Immunology: In Practice, 10(5), 1155-1167.
4. Kardaun, S. H., Sekula, P., Valeyrie-Allanore, L., et al. (2013). Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. British Journal of Dermatology, 169(5), 1071-1080.
5. Mockenhaupt, M. (2011). The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis. Expert Review of Clinical Immunology, 7(6), 803-813.
6. Ubukata, N., Hashizume, H., Nakatani, E., et al. (2024). Risk factors and drugs associated with the development of drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Journal of the American Academy of Dermatology, 91(3), 573-575.
7. Roujeau, J. C. (2005). Predictive value of SCORTEN of mortality in toxic epidermal necrolysis. Journal of Investigative Dermatology, 124(1), 26-27.
8. Choi, H., Castillo, B., & Seminario‐Vidal, L. (2018). Silver absorption in patients with Stevens‐Johnson syndrome and toxic epidermal necrolysis treated with silver‐impregnated dressings. A case series. International Wound Journal, 15(6), 1049-1051.
9. Marks, M. E., Botta, R. K., Abe, R., et al. (2023). Updates in SJS/TEN: collaboration, innovation, and community. Frontiers in Medicine
10. Creamer, D., Walsh, S. A., Dziewulski, P., et al. (2016). U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016. British Journal of Dermatology, 174(6), 1194-1227.
11. Bastuji-Garin, S., Fouchard, N., Bertocchi, M., et al. (2000). SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. Journal of Investigative Dermatology, 115(2), 149-153.
12. Foppiani, J., et al. (2024). Fractional CO₂ with 5-FU in significant scar improvement. Lasers in Medical Science, 39(1).
13. Liu, A., et al. (2020). Efficacy of combination therapies in hypertrophic scar cases. Dermatologic Surgery, 46(10).
14. De Jong, R., & Shysh, A. J. (2018). Development of a Multimodal Analgesia Protocol for Perioperative Acute Pain Management for Lower Limb Amputation. Pain Research and Management, 2018, 1-9.
15. Younes, B., Mandour, E., Hashish, M. S., & Shoukr, T. G. (2025). The Efficacy of Fractional CO2 Laser with or Without Triamcinolone Acetonide or 5-Fluorouracil in the Treatment of Early Postburn Hypertrophic Scars. Lasers in Medical Science, 40(1).
16. Raslan, E. E., et al. (2024). The Efficacy of Botulinum Toxin Type A (BTA) in the Treatment of Hypertrophic Scars and Keloids: A Systematic Review and Meta-Analysis. Cureus, 16(5).
17. Lai, I. C., et al. (2025). Comparative Efficacy and Recurrence Risk of Intralesional Therapies for Hypertrophic Scars and Keloids: A Network Meta-Analysis. Aesthetic Surgery Journal, 45(2).
18. Yang, et al. (2021). Multimodal approaches using Botulinum toxin A in scar modulation. Journal of Cosmetic Dermatology, 20(4).
19. Shiohara, T., & Mizukawa, Y. (2019). Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): an update in 2019. Allergology International, 68(3), 301-308.
20. Chen, Y. C., et al. (2015). Human herpes virus reactivations and dynamic cytokine profiles in patients with cutaneous adverse drug reactions. Allergy, 70(5), 568-575.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr. Naineni Prakash Mahesh Kumar
Associate Professor, Department Of General Medicine, Iq-City Medical College, Durgapur
Dr. Charupalli Keerthi
Assistant Professor, Department Of Dermatology, Meenakshi Medical College Hospital And Research Institute
Dr. Yamini Sivani Kannegant
Assistant Professor, Department Of Anesthesiology, Mamta Medical College, Khammam (Also
